 |
PDBsum entry 7b5o
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transcription
|
PDB id
|
|
|
|
7b5o
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
65 a.a.
|
 |
|
|
|
|
|
|
|
281 a.a.
|
 |
|
|
|
|
|
|
|
297 a.a.
|
 |
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transcription
|
 |
|
Title:
|
 |
Cryo-em structure of the human cak bound to icec0942 at 2.5 angstroms resolution
|
|
Structure:
|
 |
Cdk-activating kinase assembly factor mat1. Chain: h. Synonym: cdk7/cyclin-h assembly factor,cyclin-g1-interacting protein, menage a trois,ring finger protein 66,ring finger protein mat1,p35, p36. Engineered: yes. Cyclin-h. Chain: i. Synonym: mo15-associated protein,p34,p37.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: mnat1, cap35, mat1, rnf66. Expressed in: trichoplusia ni. Expression_system_taxid: 7111. Expression_system_cell_line: high5. Gene: ccnh. Gene: cdk7, cak, cak1, cdkn7, mo15, stk1.
|
|
Authors:
|
 |
B.J.Greber,J.Remis,S.Ali,E.Nogales
|
|
Key ref:
|
 |
B.J.Greber
et al.
(2021).
2.5 Å-resolution structure of human CDK-activating kinase bound to the clinical inhibitor ICEC0942.
Biophys J,
120,
677-686.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
05-Dec-20
|
Release date:
|
10-Feb-21
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P51948
(MAT1_HUMAN) -
CDK-activating kinase assembly factor MAT1 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
309 a.a.
65 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class 1:
|
 |
Chains H, I:
E.C.?
|
|
 |
 |
 |
 |
 |
Enzyme class 2:
|
 |
Chain J:
E.C.2.7.11.22
- cyclin-dependent kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
|
1.
|
L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
|
|
2.
|
L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
|
|
 |
 |
 |
 |
 |
L-seryl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-seryl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
L-threonyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-threonyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
Chain J:
E.C.2.7.11.23
- [RNA-polymerase]-subunit kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
[DNA-directed RNA polymerase] + ATP = phospho-[DNA-directed RNA polymerase] + ADP + H+
|
 |
 |
 |
 |
 |
[DNA-directed RNA polymerase]
|
+
|
ATP
|
=
|
phospho-[DNA-directed RNA polymerase]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Biophys J
120:677-686
(2021)
|
|
PubMed id:
|
|
|
|
|
| |
|
2.5 Å-resolution structure of human CDK-activating kinase bound to the clinical inhibitor ICEC0942.
|
|
B.J.Greber,
J.Remis,
S.Ali,
E.Nogales.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The human CDK-activating kinase (CAK), composed of CDK7, cyclin H, and MAT1, is
involved in the control of transcription initiation and the cell cycle. Because
of these activities, it has been identified as a promising target for cancer
chemotherapy. A number of CDK7 inhibitors have entered clinical trials, among
them ICEC0942 (also known as CT7001). Structural information can aid in
improving the affinity and specificity of such drugs or drug candidates,
reducing side effects in patients. Here, we have determined the structure of the
human CAK in complex with ICEC0942 at 2.5 Å-resolution using cryogenic
electron microscopy. Our structure reveals conformational differences of
ICEC0942 compared with previous X-ray crystal structures of the CDK2-bound
complex, and highlights the critical ability of cryogenic electron microscopy to
resolve structures of drug-bound protein complexes without the need to
crystalize the protein target.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
| |